Corey Leblanc, PA-C in Newport, VT - Physician Assistant

Corey Leblanc, PA-C is a Physician Assistant based in Newport, Vermont. Corey Leblanc is licensed to practice in Vermont (license number 055.0031397) and his current practice location is 2559 Glen Rd, Newport, Vermont. He can be reached at his office (for appointments etc.) via phone at (802) 334-3364.

NPI number for Corey Leblanc is 1265777882 and his current mailing address is 164 Leadville Rd, Newport Center, Vermont. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1265777882.

Contact Information

	Corey Leblanc, PA-C
	2559 Glen Rd, Newport, VT 05855-9758
	(802) 334-3364
	Not Available

Healthcare Provider's Profile

Full Name	Corey Leblanc
Gender	Male
Speciality	Physician Assistant
Location	2559 Glen Rd, Newport, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1265777882
Provider Enumeration Date: 12/07/2012
Last Update Date: 09/13/2018

Medical Identifiers

Medical identifiers for Corey Leblanc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265777882	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	040.0086261 (Vermont)	Secondary
363A00000X	Physician Assistant	055.0031397 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Corey Leblanc is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Corey Leblanc, PA-C 164 Leadville Rd, Newport Center, VT 05857-9495 Ph: (802) 272-7772	Corey Leblanc, PA-C 2559 Glen Rd, Newport, VT 05855-9758 Ph: (802) 334-3364

News Archive

OxyContin drug company sued for millions

A private company in the United States is being sued by a number of counties in the state of Kentucky over the potent painkilling drug OxyContin.

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.

Hardship exemptions allow some to continue to buy coverage on health law's marketplaces

Elsewhere, the San Jose Mercury News examines who can opt out of the health law's mandate to have insurance on religious grounds.

Hospitals in Florida, New York try new ways to boost finances

Jackson Health System in Florida is trying to boost profitable services but faces one overwhelming challenge, They don't know which procedures make money, The Miami Herald reports.

Corey Leblanc, PA-C - in Newport, VT